In conclusion, we believe that the present observations point to and strengthen the idea that therapeutic mimicking of WNT5A signaling could—via impaired β-catenin signaling—be an attractive means to reduce the niche of colon cancer stem cells and thereby prolong recurrence-free survival of colon cancer patients. This evidence concerns the gene WNT5A and malignant colon neoplasm.